The current PMCB market cap is 18.95M. The company's latest EPS is USD -0.5009 and P/E is -4.39.
Quarter End | Oct 2022 | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -2.32M | -1.55M | -902k | -2.08M | -1.41M |
Net Income | -1.88M | -764k | -126k | -3.5M | -5.53M |
Year End April 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -4.1M | -3.83M | -3.62M | -4.39M | -6.46M |
Net Income | -4.07M | -3.83M | -3.55M | -4.24M | -4.32M |
Quarter End | Oct 2022 | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 82.35M | 77.95M | 73.28M | 79.88M | 78.88M |
Total Liabilities | 1.31M | 828k | 587k | 20.4M | 20.81M |
Total Equity | 81.04M | 77.12M | 72.69M | 42.73M | 36.77M |
Year End April 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 5.78M | 6.17M | 7.4M | 90.62M | 73.28M |
Total Liabilities | 742k | 1.08M | 725k | 704k | 587k |
Total Equity | 5.04M | 5.09M | 6.68M | 89.92M | 72.69M |
Quarter End | Oct 2022 | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -2.96M | -3.51M | -3.79M | 344k | -1.64M |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | -5.48M | -9.25M | -13.56M | 6.28M | 7.03M |
Year End April 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -2.88M | -2.34M | -3.33M | -4.12M | -3.79M |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | 2.34M | 2.73M | 4.64M | 87.31M | -13.56M |
Market Cap | 18.95M |
Price to Earnings Ratio | -4.39 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.28 |
Price to Book Ratio | 0.26 |
Dividend Yield | - |
Shares Outstanding | 8.62M |
Average Volume (1 week) | 18.32k |
Average Volume (1 Month) | 41.31k |
52 Week Change | -25.93% |
52 Week High | 3.23 |
52 Week Low | 1.92 |
Spread (Intraday) | 0.68 (24.73%) |
Company Name | PharmaCyte Biotech Inc |
Address |
401 ryland st ste 200-a reno, nevada 89502 |
Website | https://ir.pharmacyte.com |
Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.